RESUMEN
OBJECTIVE: To evaluate the efficacy of a pediatric headache infusion center (HIC) in alleviating the symptoms and preventing future visits to the emergency department (ED). BACKGROUND: Headache is a common reason for visits to the pediatric ED. ED visits are associated with inordinate costs of care and are conceived by parents to be avoidable if adequate alternatives are available. An infusion center for acute treatment of intractable headache in children with chronic migraine may be an effective alternative to an ED visit. METHODS: This was a retrospective analysis of data from a single-center cohort of patients with a known history of chronic migraine, presenting to Dayton Children's HIC with an acute migraine from June 1, 2017 to June 1, 2020. Patients were treated according to established protocols divided into two pathways. Patient demographics, clinical characteristics, pre- and postinfusion pain scores, ED visits and inpatient admissions within 2 weeks of HIC visit, and ED visits 1 year prior and 1 year after the HIC visit were noted. RESULTS: A total of 297 HIC visits were analyzed from 201 patients. The HIC was effective in controlling symptoms with a significant reduction in pain score (median [interquartile range; IQR] 7.0 [2.0] preinfusion vs. 1.0 [2.0] postinfusion, p < 0.001). Only 25/297 (8.4%) patients came to the ED within 2 weeks of the HIC visit, and an even smaller number of patients (20/297, 6.7%) were admitted as inpatients within 2 weeks of the HIC visit. The number of ED visits was significantly reduced in the year after the HIC visit compared with the year prior (median [IQR] 1.0 [2.0] before vs. 0.0 [1.0] after, p < 0.001). CONCLUSION: A pediatric HIC is effective in alleviating the symptoms and preventing ED visits. These centers should be considered as standard of care at children's hospitals.
Asunto(s)
Analgésicos/administración & dosificación , Servicio de Urgencia en Hospital/estadística & datos numéricos , Costos de la Atención en Salud/estadística & datos numéricos , Hospitales Pediátricos/estadística & datos numéricos , Trastornos Migrañosos/tratamiento farmacológico , Evaluación de Procesos y Resultados en Atención de Salud , Servicio Ambulatorio en Hospital/estadística & datos numéricos , Admisión del Paciente/estadística & datos numéricos , Adolescente , Niño , Enfermedad Crónica , Servicio de Urgencia en Hospital/economía , Femenino , Hospitales Pediátricos/economía , Humanos , Infusiones Intravenosas , Masculino , Trastornos Migrañosos/economía , Servicio Ambulatorio en Hospital/economía , Dimensión del Dolor , Admisión del Paciente/economía , Estudios RetrospectivosAsunto(s)
Prueba de COVID-19/métodos , COVID-19/diagnóstico , Arquitectura y Construcción de Instituciones de Salud/métodos , Control de Infecciones/métodos , Servicio Ambulatorio en Hospital , Filtros de Aire , Boston , Prueba de COVID-19/economía , Diseño de Equipo , Ergonomía , Arquitectura y Construcción de Instituciones de Salud/economía , Implementación de Plan de Salud , Humanos , Control de Infecciones/economía , Control de Infecciones/normas , Servicio Ambulatorio en Hospital/economía , Equipo de Protección Personal/estadística & datos numéricos , Mejoramiento de la Calidad/economía , Estudios Retrospectivos , SARS-CoV-2RESUMEN
OBJECTIVE: To describe the cost of integrating social needs activities into a health care program that works toward health equity by addressing socioeconomic barriers. DATA SOURCES/STUDY SETTING: Costs for a heart failure health care program based in a safety-net hospital were reported by program staff for the program year May 2018-April 2019. Additional data sources included hospital records, invoices, and staff survey. STUDY DESIGN: We conducted a retrospective, cross-sectional, case study of a program that includes health education, outpatient care, financial counseling and free medication; transportation and home services for those most in need; and connections to other social services. Program costs were summarized overall and for mutually exclusive categories: health care program (fixed and variable) and social needs activities. DATA COLLECTION: Program cost data were collected using a activity-based, micro-costing approach. In addition, we conducted a survey that was completed by key staff to understand time allocation. PRINCIPAL FINDINGS: Program costs were approximately $1.33 million, and the annual per patient cost was $1455. Thirty percent of the program costs was for social needs activities: 18% for 30-day supply of medications and addressing socioeconomic barriers to medication adherence, 18% for mobile health services (outpatient home visits), 53% for navigating services through a financial counselor and community health worker, and 12% for transportation to visits and addressing transportation barriers. Most of the program costs were for personnel: 92% of the health care program fixed, 95% of the health care program variable, and 78% of social needs activities. DISCUSSION: Historically, social and health care services are funded by different systems and have not been integrated. We estimate the cost of implementing social needs activities into a health care program. This work can inform implementation for hospitals attempting to address social determinants of health and social needs in their patient population.
Asunto(s)
Manejo de la Enfermedad , Insuficiencia Cardíaca/terapia , Servicio Ambulatorio en Hospital/organización & administración , Proveedores de Redes de Seguridad/organización & administración , Estudios Transversales , Georgia , Educación en Salud/organización & administración , Servicios de Atención de Salud a Domicilio/organización & administración , Humanos , Cumplimiento de la Medicación , Servicio Ambulatorio en Hospital/economía , Estudios Retrospectivos , Proveedores de Redes de Seguridad/economía , Servicio Social/organización & administración , Factores Socioeconómicos , TransportesRESUMEN
BACKGROUND: In 2016, a preoperative clinic was implemented to screen, evaluate, and manage anemia and suboptimal iron stores at a major tertiary care medical center in Western Australia. Few studies compare the costs and reimbursements associated with preoperative anemia and suboptimal iron stores management. The objective of our study was to conduct a net cost analysis associated with the implementation of this clinic. METHODS: We designed a retrospective cohort study involving elective colorectal surgical admissions over a 3-year period. The baseline year selected was the 2015-2016 financial year, with outcomes in the 2016-2017 and 2017-2018 year compared to baseline. The study perspective was the Western Australian Health System. Hospital costs were extracted from the health service clinical costing system, which captures costs at the admission level. The primary outcome was net cost, defined as gross cost minus reimbursement (or funding) received. RESULTS: Our 3-year study included 544 admissions for elective colorectal surgery. After the implementation of the preoperative clinic, 73.4% (n = 257) of admissions were screened for anemia and suboptimal iron stores, and 31.4% (n = 110) received intravenous iron. In our adjusted analysis, when comparing the final year (2017-2018) with baseline (2015-2016), the units of red blood cells transfused per admission decreased 53% (142 vs 303 units per 1000 discharges; P = .006), and mean hospital length of stay decreased 15% (7.7 vs 9.1 days; P = .008). When comparing the final year with baseline, rectal resection admissions were associated with a mean decrease in the net cost of Australian dollar (A$) 7619 (95% confidence interval, 4230-11,008; P < .001) between 2015-2016 and 2017-2018. For small and large bowel procedures, there was a mean decrease of A$6744 (95% confidence interval, 2430-11,057; P = .002). CONCLUSIONS: The implementation of a preoperative anemia and suboptimal iron stores screening and management clinic in elective colorectal surgery was associated with reductions in red cell transfusions, length of stay, and net costs.
Asunto(s)
Anemia/tratamiento farmacológico , Anemia/economía , Enfermedades del Colon/economía , Enfermedades del Colon/cirugía , Procedimientos Quirúrgicos del Sistema Digestivo/economía , Planes de Aranceles por Servicios , Costos de Hospital , Tiempo de Internación/economía , Servicio Ambulatorio en Hospital/economía , Enfermedades del Recto/economía , Enfermedades del Recto/cirugía , Anciano , Anemia/sangre , Anemia/diagnóstico , Biomarcadores/sangre , Enfermedades del Colon/diagnóstico , Ahorro de Costo , Análisis Costo-Beneficio , Procedimientos Quirúrgicos del Sistema Digestivo/efectos adversos , Transfusión de Eritrocitos/economía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfermedades del Recto/diagnóstico , Estudios Retrospectivos , Factores de Tiempo , Resultado del Tratamiento , Australia OccidentalRESUMEN
OBJECTIVE: To evaluate the impact of the routine use of musculoskeletal ultrasound (MSUS) in rheumatology clinics by comparing one clinic with on-site MSUS (REU 1) and four clinics without this resource, which need to refer patients for the MSUS exams (REU 2-5). METHODS: The electronic medical records of all new patients at five rheumatology clinics during a 12-month period were reviewed. The impact of MSUS was analysed by comparing the percentage of direct discharges of patients from the different clinics, as an outcome of effectiveness, and the number and cost of radiology referrals for imaging exams (MSUS and MRI), as an outcome of cost-saving. RESULTS: The medical records of 4923 patients were included in the study, distributed as follows: REU 1, 1464 (29.7%); REU 2, 1042 (21.2%); REU 3, 1089 (22.1%); REU 4, 579 (11.8%); and REU 5, 749 (15.2%). There were more direct discharges from REU 1 (34.4%) than from REU 2-5 (15.6%) (P<0.001). REU 1 made radiological referrals for X-rays, MRIs or MSUS exams in 773 (52.8%) patients, compared with 2626 (75.9%) patients in REU 2-5 (P<0.001). An estimation of costs for the clinical assessment of 1000 new patients revealed a cost-saving in REU 1 of 21 413 in MSUS and of 877 in MRI exams. CONCLUSION: The implementation of on-site MSUS in a new-patient rheumatology clinic is cost-effective, facilitating the direct discharge of patients and reducing the number and cost of radiological referrals for imaging exams.
Asunto(s)
Enfermedades Musculoesqueléticas/diagnóstico por imagen , Servicio Ambulatorio en Hospital/economía , Ultrasonografía/economía , Estudios de Cohortes , Análisis Costo-Beneficio , Femenino , Humanos , Masculino , Persona de Mediana Edad , Derivación y Consulta/estadística & datos numéricos , Estudios Retrospectivos , EspañaAsunto(s)
Atención Ambulatoria/economía , Dermatitis Atópica/economía , Dermatitis Atópica/terapia , Servicio de Urgencia en Hospital/economía , Adulto , Niño , Dermatitis Atópica/diagnóstico , Femenino , Humanos , Masculino , Servicio Ambulatorio en Hospital/economía , Pacientes Ambulatorios/estadística & datos numéricos , Admisión del Paciente/economía , Estados UnidosRESUMEN
INTRODUCTION: Visits due to headaches are the most frequent cause of demand for neurological treatment in primary care and neurology services. Headache units improve the quality of care, reduce waiting lists, facilitate access to new treatments of proven efficacy and optimise healthcare expenditure. However, these units have not been implemented on a widespread basis in Spain due to the relatively low importance attributed to the condition and also the assumption that such units have a high cost. AIM: To define the structure and minimum requirements of a headache unit with the intention of contributing to their expansion in hospitals in Spain. SUBJECTS AND METHODS: We conducted a consensus study among professionals after reviewing the literature on the structure, functions and resources required by a headache unit designed to serve an area with 350,000 inhabitants. RESULTS: Eight publications were taken as a reference for identifying the minimum resources needed for a headache unit. The panel of experts was made up of 12 professionals from different specialties. The main resource required to be able to implement these units is the professional staff (both supervisory and technical), which can mean an additional cost for the first year of around 107,287.19 euros. CONCLUSIONS: If we bear in mind the direct and indirect costs due to losses in labour productivity per patient and compare them with the estimated costs involved in implementing these units and their expected results, everything points to the need for headache units to become generalised in Spain.
TITLE: Unidades especializadas de cefalea, una alternativa viable en España.Introducción. Las consultas por cefalea son el motivo más frecuente de demanda de atención de causa neurológica en la atención primaria y en los servicios de neurología. Las unidades de cefalea mejoran la calidad asistencial, reducen las listas de espera, facilitan el acceso a nuevos tratamientos de eficacia contrastada y optimizan el gasto sanitario. No obstante, la implantación de estas unidades no está extendida en España debido a la relativa importancia atribuida a la patología y a la suposición de que su coste es elevado. Objetivo. Definir la estructura y los requerimientos mínimos de una unidad de cefalea con la intención de contribuir a su extensión en los hospitales de España. Sujetos y métodos. Estudio de consenso entre profesionales tras la revisión de la bibliografía sobre la estructura, las funciones y los recursos de una unidad de cefalea para un área de 350.000 habitantes. Resultados. Se tomaron como referencia ocho publicaciones para la identificación de recursos mínimos necesarios de una unidad de cefalea. El panel de expertos estuvo integrado por 12 profesionales de diferentes especialidades. El principal recurso para la implementación de estas unidades son profesionales (superiores y técnicos), lo que puede suponer un coste adicional para el primer año de alrededor de 107.287,19 euros. Conclusiones. Si consideramos los costes directos e indirectos debidos a las pérdidas por productividad laboral por paciente y los comparamos con los costes estimados de implantación de estas unidades y su expectativa de resultados, todo apunta a que es necesaria la generalización de unidades de cefalea en España.
Asunto(s)
Instituciones de Atención Ambulatoria/organización & administración , Cefalea , Absentismo , Instituciones de Atención Ambulatoria/economía , Costo de Enfermedad , Análisis Costo-Beneficio , Estudios de Factibilidad , Cefalea/economía , Cefalea/epidemiología , Gastos en Salud , Promoción de la Salud , Recursos en Salud , Necesidades y Demandas de Servicios de Salud , Humanos , Trastornos Migrañosos/economía , Trastornos Migrañosos/epidemiología , Neurología/instrumentación , Neurología/organización & administración , Servicio Ambulatorio en Hospital/economía , Servicio Ambulatorio en Hospital/organización & administración , Investigación Cualitativa , España/epidemiologíaRESUMEN
Financial crisis has forced health systems to seek alternatives to hospitalization-based healthcare. Quick diagnosis units (QDUs) are cost-effective compared to hospitalization, but the determinants of QDU costs have not been studied.We aimed at assessing the predictors of costs of a district hospital QDU (Hospital Plató, Barcelona) between 2009 and 2016.This study was a retrospective longitudinal single center study of 404 consecutive outpatients referred to the QDU of Hospital Plató. The referral reason was dichotomized into suggestive of malignancy vs other. The final diagnosis was dichotomized into organic vs nonorganic and malignancy vs nonmalignancy. All individual resource costs were obtained from the finance department to conduct a micro-costing analysis of the study period.Mean age was 62â±â20 years (womenâ=â56%), and median time-to-diagnosis, 12 days. Total and partial costs were greater in cases with final diagnosis of organic vs nonorganic disorder, as it was in those with symptoms suggestive or a final diagnosis of cancer vs noncancer. Of all subcosts, imaging showed the stronger correlation with total cost. Time-to-diagnosis and imaging costs were significant predictors of total cost above the median in binary logistic regression, with imaging costs also being a significant predictor in multiple linear regression (with total cost as quantitative outcome).Predictors of QDU costs are partly nonmodifiable (i.e., cancer suspicion, actually one of the goals of QDUs). Yet, improved primary-care-to-hospital referral circuits reducing time to diagnosis as well as optimized imaging protocols might further increase the QDU cost-effectiveness process. Prospective studies (ideally with direct comparison to conventional hospitalization costs) are needed to explore this possibility.
Asunto(s)
Costos de Hospital/estadística & datos numéricos , Hospitales Públicos/economía , Servicio Ambulatorio en Hospital/economía , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Hospitales Públicos/organización & administración , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Neoplasias/diagnóstico , Servicio Ambulatorio en Hospital/organización & administración , Servicio Ambulatorio en Hospital/estadística & datos numéricos , Derivación y Consulta/economía , Estudios Retrospectivos , España , Factores de TiempoRESUMEN
INTRODUCTION: Patient evaluation before cardiac resynchronisation therapy (CRT) remains heterogeneous across centres and it is suspected a proportion of patients with unfavourable characteristics proceed to implantation. We developed a unique CRT preassessment clinic (CRT PAC) to act as a final review for patients already considered for CRT. We hypothesised that this clinic would identify some patients unsuitable for CRT through updated investigations and review. The purpose of this analysis was to determine whether the CRT PAC led to savings for the National Health Service (NHS). METHODS: A decision tree model was made to evaluate two clinical pathways; (1) standard of care where all patients initially seen in an outpatient cardiology clinic proceeded directly to CRT and (2) management of patients in CRT PAC. RESULTS: 244 patients were reviewed in the CRT PAC; 184 patients were eligible to proceed directly for implantation and 48 patients did not meet consensus guidelines for CRT so were not implanted. Following CRT, 82.4% of patients had improvement in their clinical composite score and 57.7% had reduction in left ventricular end-systolic volume ≥15%. Using the decision tree model, by reviewing patients in the CRT PAC, the total savings for the NHS was £966 880. Taking into consideration the additional cost of the clinic and by applying this model structure throughout the NHS, the potential savings could be as much as £39 million. CONCLUSIONS: CRT PAC appropriately selects patients and leads to substantial savings for the NHS. Adopting this clinic across the NHS has the potential to save £39 million.
Asunto(s)
Terapia de Resincronización Cardíaca/economía , Toma de Decisiones Clínicas , Prestación Integrada de Atención de Salud/economía , Costos de la Atención en Salud , Cardiopatías/economía , Cardiopatías/terapia , Servicio Ambulatorio en Hospital/economía , Selección de Paciente , Medicina Estatal/economía , Anciano , Anciano de 80 o más Años , Terapia de Resincronización Cardíaca/efectos adversos , Ahorro de Costo , Análisis Costo-Beneficio , Técnicas de Apoyo para la Decisión , Árboles de Decisión , Prestación Integrada de Atención de Salud/organización & administración , Femenino , Cardiopatías/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Modelos Económicos , Servicio Ambulatorio en Hospital/organización & administración , Evaluación de Programas y Proyectos de Salud , Derivación y Consulta/economía , Medicina Estatal/organización & administración , Reino UnidoRESUMEN
BACKGROUND: Health insurance reimbursement structure has evolved, with patients becoming increasingly responsible for their health care costs through rising out-of-pocket expenses. High levels of cost sharing can lead to delays in access to care, influence treatment decisions, and cause financial distress for patients. METHODS: Patients undergoing the most common outpatient reconstructive plastic surgery operations were identified using Truven MarketScan databases from 2009 to 2017. Total cost of the surgery paid to the insurer and out-of-pocket expenses, including deductible, copayment, and coinsurance, were calculated. Multivariable generalized linear modeling with log link and gamma distribution was used to predict adjusted total and out-of-pocket expenses. All costs were inflation-adjusted to 2017 dollars. RESULTS: The authors evaluated 3,165,913 outpatient plastic and reconstructive surgical procedures between 2009 and 2017. From 2009 to 2017, total costs had a significant increase of 25 percent, and out-of-pocket expenses had a significant increase of 54 percent. Using generalized linear modeling, procedures performed in outpatient hospitals conferred an additional $1999 in total costs (95 percent CI, $1978 to $2020) and $259 in out-of-pocket expenses (95 percent CI, $254 to $264) compared with office procedures. Ambulatory surgical center procedures conferred an additional $1698 in total costs (95 percent CI, $1677 to $1718) and $279 in out-of-pocket expenses (95 percent CI, $273 to $285) compared with office procedures. CONCLUSIONS: For outpatient plastic surgery procedures, out-of-pocket expenses are increasing at a faster rate than total costs, which may have implications for access to care and timing of surgery. Providers should realize the increasing burden of out-of-pocket expenses and the effect of surgical location on patients' costs when possible.
Asunto(s)
Procedimientos Quirúrgicos Ambulatorios/economía , Seguro de Costos Compartidos/estadística & datos numéricos , Gastos en Salud/estadística & datos numéricos , Reembolso de Seguro de Salud/economía , Procedimientos de Cirugía Plástica/economía , Adolescente , Adulto , Anciano , Procedimientos Quirúrgicos Ambulatorios/estadística & datos numéricos , Ahorro de Costo/economía , Ahorro de Costo/legislación & jurisprudencia , Seguro de Costos Compartidos/economía , Seguro de Costos Compartidos/legislación & jurisprudencia , Seguro de Costos Compartidos/tendencias , Bases de Datos Factuales/estadística & datos numéricos , Planes de Aranceles por Servicios/economía , Planes de Aranceles por Servicios/legislación & jurisprudencia , Planes de Aranceles por Servicios/estadística & datos numéricos , Planes de Aranceles por Servicios/tendencias , Femenino , Gastos en Salud/legislación & jurisprudencia , Gastos en Salud/tendencias , Precios de Hospital/estadística & datos numéricos , Precios de Hospital/tendencias , Humanos , Reembolso de Seguro de Salud/legislación & jurisprudencia , Reembolso de Seguro de Salud/tendencias , Masculino , Programas Controlados de Atención en Salud/economía , Programas Controlados de Atención en Salud/legislación & jurisprudencia , Programas Controlados de Atención en Salud/estadística & datos numéricos , Programas Controlados de Atención en Salud/tendencias , Medicare/economía , Medicare/legislación & jurisprudencia , Medicare/estadística & datos numéricos , Medicare/tendencias , Persona de Mediana Edad , Servicio Ambulatorio en Hospital/economía , Servicio Ambulatorio en Hospital/estadística & datos numéricos , Políticas , Procedimientos de Cirugía Plástica/estadística & datos numéricos , Estudios Retrospectivos , Estados Unidos , Adulto JovenAsunto(s)
Dermatólogos/economía , Reforma de la Atención de Salud/economía , Reembolso de Seguro de Salud/economía , Centros Médicos Académicos/economía , Centros Médicos Académicos/estadística & datos numéricos , Estudios Transversales , Humanos , Medicare/economía , Visita a Consultorio Médico/economía , Visita a Consultorio Médico/estadística & datos numéricos , Servicio Ambulatorio en Hospital/economía , Servicio Ambulatorio en Hospital/estadística & datos numéricos , Estados UnidosAsunto(s)
Betacoronavirus/patogenicidad , Infecciones por Coronavirus/prevención & control , Servicio Ambulatorio en Hospital/organización & administración , Pandemias/prevención & control , Neumonía Viral/prevención & control , Telemedicina/organización & administración , Enfermedades Vasculares/terapia , COVID-19 , Centers for Medicare and Medicaid Services, U.S./economía , Centers for Medicare and Medicaid Services, U.S./legislación & jurisprudencia , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/transmisión , Infecciones por Coronavirus/virología , Humanos , Cobertura del Seguro/economía , Cobertura del Seguro/legislación & jurisprudencia , Seguro de Salud/economía , Seguro de Salud/legislación & jurisprudencia , Servicio Ambulatorio en Hospital/economía , Servicio Ambulatorio en Hospital/legislación & jurisprudencia , Servicio Ambulatorio en Hospital/normas , Neumonía Viral/epidemiología , Neumonía Viral/transmisión , Neumonía Viral/virología , Políticas , Guías de Práctica Clínica como Asunto , SARS-CoV-2 , Sociedades Médicas/normas , Telemedicina/economía , Telemedicina/legislación & jurisprudencia , Telemedicina/normas , Triaje/normas , Estados Unidos/epidemiología , Enfermedades Vasculares/diagnósticoRESUMEN
BACKGROUND: This study aimed to determine the lifetime cost-effectiveness of first-line dialysis modalities for end-stage renal disease (ESRD) patients under the "Peritoneal Dialysis First" policy. METHODS: Lifetime cost-effectiveness analyses from both healthcare provider and societal perspectives were performed using Markov modelling by simulating at age 60. Empirical data on costs and health utility scores collected from our studies were combined with published data on health state transitions and survival data to estimate the lifetime cost, quality-adjusted life-years (QALYs) and cost-effectiveness of three competing dialysis modalities: peritoneal dialysis (PD), hospital-based haemodialysis (HD) and nocturnal home HD. RESULTS: For cost-effectiveness analysis over a lifetime horizon from the perspective of healthcare provider, hospital-based HD group (lifetime cost USD$142,389; 6.58 QALYs) was dominated by the PD group (USD$76,915; 7.13 QALYs). Home-based HD had the highest effectiveness (8.37 QALYs) but with higher cost (USD$97,917) than the PD group. The incremental cost-effectiveness ratio (ICER) was USD$16,934 per QALY gained for home-based HD over PD. From the societal perspective, the results were similar and the ICER was USD$1195 per QALY gained for home-based HD over PD. Both ICERs fell within the acceptable thresholds. Changes in model parameters via sensitivity analyses had a minimal impact on ICER values. CONCLUSIONS: This study assessed the cost-effectiveness of dialysis modalities and service delivery models for ESRD patients under "Peritoneal Dialysis First" policy. For both healthcare provider and societal perspectives, PD as first-line dialysis modality was cost-saving relative to hospital-based HD, supporting the existing PD First or favoured policy. When compared with PD, Nocturnal home Home-based HD was considered a cost-effective first-line dialysis modality for ESRD patients.
Asunto(s)
Costos de la Atención en Salud/estadística & datos numéricos , Hemodiálisis en el Domicilio/economía , Fallo Renal Crónico/economía , Fallo Renal Crónico/terapia , Diálisis Peritoneal/economía , Análisis Costo-Beneficio , Humanos , Cadenas de Markov , Persona de Mediana Edad , Servicio Ambulatorio en Hospital/economía , Años de Vida Ajustados por Calidad de VidaRESUMEN
AIM: Skin substitutes are frequently used to treat chronic diabetic foot ulcers (DFU), and many different options are available. While the clinical efficacy of many products has been evaluated, a comprehensive cost-effectiveness analysis comparing the most popular skin substitutes and using the most recent cost data has been lacking. METHODS: This study compared eight skin substitutes using published efficacy rates combined with the Centers for Medicare and Medicaid Services (CMS) 2018 cost data. The study criteria resulted in the inclusion of seven studies that described efficacy rates for treatment of DFUs using the skin substitutes. RESULTS: The results revealed wide discrepancies between these skin substitutes for the costs of treatments and healing rates in hospital outpatient departments and physician office settings. Healing rates for 12 and 16 weeks ranged from 28% to 68%, while the average cost for treating one DFU varied from $2001 to $14,507 and $1207 to $8791 in the hospital outpatient department and physician's office setting, respectively. The estimated patient share of costs for treating a single DFU ranged from $400 to $2901 and $241 to $1758 in the hospital outpatient department and physician's office setting, respectively. Most importantly, the estimated number of wounds healed out of 100 DFUs per $1000 expenditure with each patient ranged from 3.9-26.5 DFUs in the hospital outpatient department, and 4.3-36.4 DFUs in the physicians' office setting. CONCLUSIONS: This study revealed that the costs of a skin substitute itself did not necessarily correlate with its healing efficacy. These results provide a comprehensive cost-effectiveness analysis to enable integrated health-care systems, health professionals and reimbursement payers to make informed value decisions when treating DFUs.
Asunto(s)
Atención Ambulatoria/economía , Pie Diabético/terapia , Gastos en Salud , Piel Artificial/economía , Cicatrización de Heridas , Instituciones de Atención Ambulatoria/economía , Apósitos Biológicos/economía , Sulfatos de Condroitina/economía , Colágeno/economía , Análisis Costo-Beneficio , Pie Diabético/economía , Humanos , Servicio Ambulatorio en Hospital/economía , Años de Vida Ajustados por Calidad de VidaRESUMEN
Acute stress disorder (ASD) and post-traumatic stress disorder (PTSD) are developed from exposure to traumatic events including war, interpersonal violence and natural disasters. We investigated prevalence and trauma-related information in patients from an outpatient psychiatric unit in Brazil among 2014-2017. A prevalence of ASD/PTSD of 40.8% was found in 179 patients. Female, Caucasian, married, mostly educated during 10-12 years long and employed patients composed a main profile. The presence of any previous trauma in adulthood and childhood were related to ASD/PTSD with longer follow-up time. This study provides evidence of stress-related disorders in a heterogeneous environment.
Asunto(s)
Servicio Ambulatorio en Hospital/economía , Pobreza/economía , Trastornos por Estrés Postraumático/economía , Trastornos por Estrés Postraumático/epidemiología , Trastornos de Estrés Traumático Agudo/economía , Trastornos de Estrés Traumático Agudo/epidemiología , Adulto , Brasil/epidemiología , Femenino , Estudios de Seguimiento , Humanos , Renta/tendencias , Masculino , Persona de Mediana Edad , Servicio Ambulatorio en Hospital/tendencias , Pacientes Ambulatorios/psicología , Pobreza/psicología , Pobreza/tendencias , Prevalencia , Trastornos por Estrés Postraumático/psicología , Trastornos de Estrés Traumático Agudo/psicología , Factores de Tiempo , Violencia/economía , Violencia/psicología , Violencia/tendenciasRESUMEN
OBJECTIVES: Data are lacking regarding implementation of novel strategies such as follow-up clinics and peer support groups, to reduce the burden of postintensive care syndrome. We sought to discover enablers that helped hospital-based clinicians establish post-ICU clinics and peer support programs, and identify barriers that challenged them. DESIGN: Qualitative inquiry. The Consolidated Framework for Implementation Research was used to organize and analyze data. SETTING: Two learning collaboratives (ICU follow-up clinics and peer support groups), representing 21 sites, across three continents. SUBJECTS: Clinicians from 21 sites. MEASUREMENT AND MAIN RESULTS: Ten enablers and nine barriers to implementation of "ICU follow-up clinics" were described. A key enabler to generate support for clinics was providing insight into the human experience of survivorship, to obtain interest from hospital administrators. Significant barriers included patient and family lack of access to clinics and clinic funding. Nine enablers and five barriers to the implementation of "peer support groups" were identified. Key enablers included developing infrastructure to support successful operationalization of this complex intervention, flexibility about when peer support should be offered, belonging to the international learning collaborative. Significant barriers related to limited attendance by patients and families due to challenges in creating awareness, and uncertainty about who might be appropriate to attend and target in advertising. CONCLUSIONS: Several enablers and barriers to implementing ICU follow-up clinics and peer support groups should be taken into account and leveraged to improve ICU recovery. Among the most important enablers are motivated clinician leaders who persist to find a path forward despite obstacles.
Asunto(s)
Enfermedad Crítica , Unidades de Cuidados Intensivos , Servicio Ambulatorio en Hospital/organización & administración , Grupos de Autoayuda/organización & administración , Sobrevivientes/psicología , Adulto , Accesibilidad a los Servicios de Salud/organización & administración , Humanos , Persona de Mediana Edad , Servicio Ambulatorio en Hospital/economía , Grupo Paritario , Investigación Cualitativa , Grupos de Autoayuda/economíaRESUMEN
OBJECTIVE: The economic pressures widely discussed in health care have a large impact on spine practices. This current study is the first to look at characteristics associated with revenues from an outpatient spine clinic. METHODS: All clinic visits to spine providers were identified at a single academic institution spanning the dates June 1, 2014, to June 1, 2018. All payment information was calculated using Medicare reimbursement values for Current Procedural Terminology codes. Relevant clinical, surgical, and cost structure data was collected for each patient. RESULTS: On average, providers had 21.9 average appointments over the course of 7.6 hours per clinic day. The average ratio of new to follow-up patients was 39.3%, with an average new patient to surgery conversion rate of 15.0%. The adjusted average total procedural revenue per new patient, controlled for scheduled appointment length and actual appointment length, was $686.02. The adjusted average procedural revenue per surgery was $3444.64 and average procedural revenue per hour in spine clinic was $552.40. With a 1% and 5% increase in new patient visits, total procedural revenue increases 2.7% and 13.5%, respectively. With a 1% and 5% increase in conversion rate, total procedural revenue increases 6.7% and 33.3%, respectively. With a decrease in new patient appointment length from 30 minutes to 25 minutes, the opportunity for 1.7 new patient appointments per day was created resulting in a net increase in procedural revenue per clinic day of $837.57. CONCLUSIONS: Incremental changes in practice structure can significantly affect procedural revenue. Significant heterogeneity also exists among spine providers.
Asunto(s)
Centros Médicos Académicos/economía , Servicio Ambulatorio en Hospital/economía , Columna Vertebral/cirugía , Centros Médicos Académicos/organización & administración , Citas y Horarios , Costos y Análisis de Costo , Humanos , Reembolso de Seguro de Salud , Medicare , Servicio Ambulatorio en Hospital/organización & administración , Pacientes Ambulatorios , Estados UnidosRESUMEN
We study the introduction of reference pricing to the California Public Employees' Retirement System. Reference pricing changes the relative price of using a hospital versus an ambulatory surgery center (ASC) for patients receiving a colonoscopy, leading to as good as random variation in patients' use of ASCs. We find a 10 percentage point increase in the share of patients using an ASC, leading to a $2300 to $1700 reduction in prices paid for patients who switch to ASCs. Our results suggest that the use of ASCs has a causal effect on prices paid and has no negative effect on patient health outcomes.